Shlomo Zohar Sells 7,343 Shares of Delek US (NYSE:DK) Stock

Delek US Holdings, Inc. (NYSE:DK) Director Shlomo Zohar sold 7,343 shares of Delek US stock in a transaction on Thursday, March 19th. The stock was sold at an average price of $46.00, for a total value of $337,778.00. Following the sale, the director directly owned 6,646 shares of the company’s stock, valued at approximately $305,716. This trade represents a 52.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shlomo Zohar also recently made the following trade(s):

• On Monday, March 9th, Shlomo Zohar sold 5,000 shares of Delek US stock. The shares were sold at an average price of $41.47, for a total value of $207,350.00.
• On Thursday, March 5th, Shlomo Zohar sold 22,029 shares of Delek US stock. The stock was sold at an average price of $44.83, for a total value of $987,560.07.
• On Wednesday, March 4th, Shlomo Zohar sold 7,343 shares of Delek US stock. The shares were sold at an average price of $43.00, for a total value of $315,749.00.

Delek US Price Performance

Shares of NYSE:DK traded down $1.93 during mid-day trading on Monday, reaching $42.31. The stock had a trading volume of 1,687,738 shares, compared to its average volume of 1,750,682. The firm has a 50 day simple moving average of $35.14 and a two-hundred day simple moving average of $34.59. Delek US Holdings, Inc. has a twelve month low of $11.02 and a twelve month high of $46.81. The company has a debt-to-equity ratio of 5.89, a quick ratio of 0.53 and a current ratio of 0.82.

Delek US (NYSE:DK) last issued its earnings results on Friday, February 27th. The oil and gas company reported $0.44 EPS for the quarter, beating the consensus estimate of ($0.19) by $0.63. The firm had revenue of $2.43 billion during the quarter, compared to the consensus estimate of $2.55 billion. Delek US had a negative net margin of 0.21% and a negative return on equity of 13.55%. The business’s quarterly revenue was up 2.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($2.54) earnings per share. Research analysts expect that Delek US Holdings, Inc. will post -5.5 earnings per share for the current year.

Delek US Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 9th. Investors of record on Monday, March 2nd were paid a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend was Monday, March 2nd. Delek US’s dividend payout ratio (DPR) is presently -291.43%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Wall Street Zen upgraded Delek US from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. Citigroup decreased their price objective on Delek US from $37.00 to $33.00 and set a “neutral” rating for the company in a research report on Monday, January 26th. Piper Sandler lowered their target price on Delek US from $47.00 to $40.00 and set a “neutral” rating for the company in a research note on Thursday, January 8th. Morgan Stanley dropped their target price on shares of Delek US from $40.00 to $38.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 27th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Delek US in a research note on Wednesday, January 21st. Four research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $39.69.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. ION Fund Management Ltd acquired a new position in Delek US during the fourth quarter worth $52,427,000. Norges Bank bought a new stake in Delek US during the fourth quarter worth $48,374,000. Arrowstreet Capital Limited Partnership lifted its stake in Delek US by 6,300.8% in the third quarter. Arrowstreet Capital Limited Partnership now owns 1,306,269 shares of the oil and gas company’s stock valued at $42,153,000 after acquiring an additional 1,285,861 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Delek US by 1,516.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 996,059 shares of the oil and gas company’s stock valued at $29,544,000 after acquiring an additional 934,448 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of Delek US by 1,173.2% during the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 954,900 shares of the oil and gas company’s stock worth $28,322,000 after purchasing an additional 879,900 shares during the last quarter. 97.01% of the stock is currently owned by institutional investors.

Delek US Company Profile

Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.

In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.